Related Experiment Videos

Combined carotid and coronary artery surgery: early and late results

T Carrel1, G Stillhard, M Turina

  • 1Clinic for Cardiovascular Surgery, University Hospital, Zürich, Switzerland.

Cardiology
|January 1, 1992
PubMed

Insights

Combined coronary artery bypass grafting (CABG) and cerebrovascular disease treatment in high-risk patients showed a 3.8% mortality rate. This combined approach yielded better long-term survival and fewer complications than staged procedures.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Vascular Surgery

Background:

  • Coronary artery disease (CAD) and extracranial cerebrovascular disease frequently coexist.
  • Patients with CAD often have significant vascular involvement, increasing their risk.
  • Symptomatic or severe asymptomatic carotid disease necessitates intervention in CAD patients.

Purpose of the Study:

  • To evaluate the safety and efficacy of combined coronary artery bypass grafting (CABG) and extracranial cerebrovascular disease treatment.
  • To compare outcomes of combined procedures versus staged interventions.
  • To assess the long-term prognosis for patients undergoing combined surgical management.

Main Methods:

  • A cohort of 52 patients with indications for both CABG and cerebrovascular intervention underwent combined procedures.
  • Comparison groups included 45 patients with staged procedures (carotid endarterectomy followed by CABG) and 42 patients with CABG and carotid bruits.
  • Data collected included hospital mortality, early complications (cardiac and neurologic), and 8-year actuarial survival.

Main Results:

  • Overall hospital mortality for the combined procedure was 3.8%, with higher risk in urgent/emergency cases.
  • Eight-year actuarial survival reached 86% for patients undergoing combined procedures.
  • Staged procedures resulted in significantly higher early cardiac complications (staged) and neurologic complications (CABG with bruits) compared to combined treatment.

Conclusions:

  • Combined CABG and cerebrovascular disease treatment is feasible with acceptable risk in selected patients.
  • The combined approach offers encouraging long-term survival and may improve prognosis for patients with diffuse atherosclerosis.
  • Combined procedures demonstrate a lower incidence of early complications compared to staged interventions for patients with concurrent coronary and carotid disease.

Related Concept Videos